MedArrive providers will use Spect's mobile telemedicine platform to perform critical eye screenings for diseases such as diabetic retinopathy, glaucoma and age-related macular degeneration. MedArrive ...
The partnership expands DocGo’s ability to support patients and vulnerable populations NEW YORK--(BUSINESS WIRE)-- DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of ...
By integrating Spect’s scalable and portable technology into DocGo’s technology and services, we can increase the number of eligible members screened, and help improve patient care and health plan ...